Indian Immunologicals Limited

Error creating thumbnail:

IIL India logo

Indian Immunologicals Limited (IIL) is a leading vaccine manufacturing company based in India. Established by the National Dairy Development Board (NDDB) in 1982, IIL is committed to improving public health through its focus on the development, production, and marketing of vaccines and bio-therapeutics.

History

Indian Immunologicals Limited was founded with the primary goal of making foot and mouth disease (FMD) vaccines accessible and affordable to the vast livestock population of India. Over the years, IIL has expanded its product portfolio to include vaccines for both animals and humans. The company's growth trajectory has been marked by significant achievements in vaccine research and development, making it a key player in the global healthcare sector.

Products and Services

IIL's product range covers a wide spectrum of vaccines for animals, including those against rabies, FMD, brucellosis, and classical swine fever, among others. In the human vaccine segment, IIL produces vaccines for rabies, measles, DPT (Diphtheria, Pertussis, Tetanus), and hepatitis B, to name a few.

The company is also involved in the research and development of novel vaccines and bio-therapeutic products. Its state-of-the-art research facilities are equipped to handle advanced biotechnological research in the field of vaccine development.

Manufacturing Facilities

IIL operates several manufacturing facilities across India, with the main plant located in Hyderabad, Telangana. These facilities are equipped with cutting-edge technology to ensure the production of high-quality vaccines that meet international standards. The company's commitment to quality is reflected in its adherence to Good Manufacturing Practices (GMP) and certification by global health authorities.

Corporate Social Responsibility

As part of its corporate social responsibility (CSR) initiatives, Indian Immunologicals Limited is actively involved in various public health campaigns and vaccination drives. The company works closely with government bodies, non-governmental organizations (NGOs), and international agencies to enhance vaccine accessibility and awareness, particularly in underprivileged and rural areas.

Research and Development

IIL's research and development efforts are focused on the innovation of new vaccines and bio-therapeutic products. The company invests significantly in R&D to address emerging health challenges and to improve the efficacy and safety of its products. Its R&D team collaborates with academic institutions and research organizations worldwide to advance vaccine technology and public health outcomes.

Global Presence

Indian Immunologicals Limited has a strong international presence, exporting its products to more than 50 countries. The company's global strategy includes partnerships and collaborations with international health organizations to contribute to global immunization programs and disease eradication efforts.

Conclusion

Indian Immunologicals Limited plays a pivotal role in the global healthcare landscape, with its comprehensive range of vaccines and bio-therapeutics. Through its commitment to quality, innovation, and social responsibility, IIL continues to make significant contributions to public health, both in India and around the world.